SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is actively discussed following a mixed earnings report, where an EPS beat was overshadowed by concerns over revenue growth and compressed margins, alongside escalating legal and regulatory challenges from Novo Nordisk, the FDA, DOJ, and SEC. Community sentiment is sharply divided, with some investors seeing a compelling buying opportunity due to perceived undervaluation and high short interest, while others highlight significant regulatory and legal risks predicting further declines.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a substantial sell-off after an Anthropic blog post highlighted its Claude AI's capability to automate COBOL modernization, fueling community debate over AI's disruptive impact on legacy services versus IBM's existing AI solutions and strategic partnerships.

SolCex is the first centralized cryptocurrency exchange launched on the Solana blockchain, offering users a seamless, secure, and accessible platform for trading a wide range of digital assets. With a focus on user experience, security, and education, SolCex aims to redefine the landscape of cryptocurrency trading, catering to both novice and experienced traders alike. This whitepaper explores the features, security measures, and vision of SolCex, outlining its role as the premier destination for trading Solana tokens and other cryptocurrencies.

SolCex

SOLCEX is gaining traction as its community eagerly anticipates the upcoming app launch and significant platform developments, believing it's positioned to become a leading centralized exchange within the burgeoning Solana ecosystem.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant attention following its public debut on the NYSE and recent institutional interest, sparking community debate over its innovative neutral-atom quantum technology and existing commercial applications in contrast to peers, amidst discussions of typical post-SPAC market dynamics.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending due to reports of a potential major sale of its orthopedics unit, signaling a strategic pivot and fueling community discussion on its impact on future growth. Simultaneously, escalating talc litigation with recent significant jury awards has sparked intense debate regarding its financial outlook as it pursues new drug approvals and cell therapy investments.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as it strategically offloads Bitcoin mining assets to Canaan and solidifies its pivot to high-margin AI data center infrastructure, a move reinforced by a new "Overweight" rating and $38 price target from Morgan Stanley, as the community discusses revenue transformation from hyperscaler contracts while anticipating upcoming earnings amidst broader market volatility.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly active and resilient community, which continues to emphasize building a multi-faceted 'brandcoin' with real-world products and initiatives despite a turbulent market. The community is actively discussing buying dips and holding strong, confident in KENDU's long-term vision and unique, permissionless brand strategy.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

XYO Network is trending due to intense community discussion surrounding speculative "groundbreaking news" and rumored integrations with Tesla or AI. This is creating a strong divide between hopeful long-term holders and frustrated critics who decry a history of "pump and dump" activity and question the project's overall direction.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending as its NEAR Intents technology drives significant cross-chain activity and integration with major ecosystems, alongside strong community discussion around its AI-native capabilities. Growing user adoption and institutional interest, including a Grayscale Trust filing, are fueling optimism for its future performance.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid intense speculation around its bid for Warner Bros. Discovery, as Paramount reportedly submits a higher offer, leading to widespread community debate on whether the streaming giant should raise its price or walk away to avoid further stock depreciation and navigate increasing regulatory and political scrutiny.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Q4 earnings season — these 5 drug &amp; biotech names could surprise to the upside

$ZTS, $PCRX, $APLS, $ACAD, and $DNLI are highlighted as poised to beat on fourth-quarter 2025 earnings, setting up a potential outperformance theme investors should have on their radar.

See which drug &amp; biotech stocks could deliver earnings upside 👉 https://www.zacks.com/stock/news/2827958/5-drugbiotech-stocks-likely-to-outperform-q4-earnings-estimates?cid=sm-stocktwits-2-2827958-teaser-31624&amp;ADID=SYND_STOCKTWITS_TWEET_2_2827958_TEASER_31624

Bull Donald

Zacks

Pardon Our Interruption

$APLS Was looking to streamline my portfolio and free up cash to buy more $GUTS, but this post by Zacks immediately changed my mind.  Thanks Zacks! 
 
Follow/Subscribe for more suggestions and perspective.  Would love to hear yours too.  That&#39;s how we find these gems and learn. 
 
Let&#39;s make some (more) money.  Cheers!

StockTwits Web

The Legendary Mayor

Zacks Research

Zoetis Inc - Ordinary Shares - Class A

Pacira BioSciences Inc

Apellis Pharmaceuticals Inc

Acadia Pharmaceuticals Inc

Denali Therapeutics Inc

Q4 earnings season — these 5 drug & biotech names could surprise to the upside



 are highlighted as poised to beat on fourth-quarter 2025 earnings, setting up a potential outperformance theme investors should have on their radar.

See which drug & biotech stocks could deliver earnings upside 👉 

This account is recognized as an Official Stocktwits Research Partner — working in close collaboration with Stocktwits to deliver in-depth research and market analysis.